SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-055451
Filing Date
2021-09-10
Accepted
2021-09-10 16:27:30
Documents
1
Period of Report
2021-09-08

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4170
  Complete submission text file 0001209191-21-055451.txt   5561
Mailing Address 200 INNER BELT ROAD SOMERVILLE MA 02143
Business Address 200 INNER BELT ROAD SOMERVILLE MA 02143 617-229-6499
Finch Therapeutics Group, Inc. (Issuer) CIK: 0001733257 (see all company filings)

IRS No.: 823433558 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O FINCH THERAPEUTICS GROUP, INC. 200 INNER BELT ROAD, SUITE 400 SOMERVILLE MA 02143
Business Address
Blaustein Marc (Reporting) CIK: 0001880032 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40227 | Film No.: 211247345